Showing results (11-20 of 170) with videos related to
Sort By:
Pageof 17
Pathologie-Biologie|February 1, 1987
[Disparity between the level of activity and immunochemical determination of terminal deoxynucleotidyl transferase in leukemia]M Marchand-Arvier, C VigneronEuropean Journal of Cancer & Clinical Oncology|November 1, 1983
Increased frequency of immunogenic variants obtained by repeated mutagen treatment of mouse mastocytoma P815M Marchand, P Caspar, T BoonJournal of Population Economics|January 1, 1991
Pay-as-you-go social security in a changing environmentR Boadway, M Marchand, P PestieauIEEE Transactions on Pattern Analysis and Machine Intelligence|May 18, 2011
Feature Selection with Conjunctions of Decision Stumps and Learning from Microarray DataM Shah, M Marchand, J CorbeilAntimicrobial Agents and Chemotherapy|November 1, 1985
Susceptibility of Campylobacter jejuni and Campylobacter coli to macrolides and related compoundsZ Elharrif, F Mégraud, A M MarchandRevue Medicale De Liege|October 5, 2001
[Finapres, efficient technique in the assessment of orthostatic hypotension, autonomic neuropathy, and vaso-vagal syncope]A J Scheen, I Geronooz, M MarchandPresse Medicale (Paris, France : 1983)|January 18, 1986
[Influence of Intralipid on the properties of circulating phagocytes]M Marchand-Arvier, P Brucker, C VigneronClinical Chemistry|September 1, 1986
Ultramicromethod for measuring the activity of terminal deoxynucleotidyl transferaseB Léotard, M Marchand-Arvier, C VigneronJournal of Pharmacokinetics and Pharmacodynamics|January 20, 2010
Supporting the recommended paediatric dosing regimen for rufinamide in Lennox-Gastaut syndrome using clinical trial simulationM Marchand, E Fuseau, D J CritchleyAnnales De Medecine Interne|January 1, 1990
[Determination of C3a and C5a in hemapheresis procedures]F Schooneman, M Marchand, C Vigneron, et al.Pageof 17